Minocycline offers no benefit in treating dry age-related macular degeneration
age-related macular degeneration

Minocycline offers no benefit in treating dry age-related macular degeneration

Minocycline, a commonly prescribed antibiotic that also offers anti-inflammatory effects, does not offer any benefits to those suffering from dry age-related macular degeneration.
Something out of science fiction: solar panels for the eyes
age related macular degeneration

Something out of science fiction: solar panels for the eyes

With new treatments and scientific advancements being announced almost on a daily basis, it shouldn't be surprising that the next "big thing" might very well be tiny solar panels for the eyes.
Visual hallucinations commonly associated with age-related macular degeneration
age related macular degeneration

Visual hallucinations commonly associated with age-related macular degeneration

Charles Bonnet Syndrome (CBS) is a condition that occurs when people lose some or all of their vision.
Artificial outdoor nighttime lights linked to higher risk of macular degeneration
age-related macular degeneration

Artificial outdoor nighttime lights linked to higher risk of macular degeneration

A study published in JAMA Network Open details the possible link of exposure to nighttime artificial outdoor lights and an increased risk of age-related macular degeneration. Researchers at Jeju N...
Phase 2b clinical trials set for potential AMD treatment
age related macular degeneration

Phase 2b clinical trials set for potential AMD treatment

More than one million Americans aged 40 and over are affected by geographic atrophy (otherwise known as advanced dry age-related macular degeneration), which currently has no available therapy that...
AMD patients with visual disability at higher risk of cardiovascular disease
age related macular degeneration

AMD patients with visual disability at higher risk of cardiovascular disease

Researchers at Sungkyunkwan University School of Medicine in Korea conducted a nationwide cohort study involving nearly 4 million adults.
FDA approves first drug to treat geographic atrophy
age-related macular degeneration

FDA approves first drug to treat geographic atrophy

Geographic atrophy typically affects people over the age of 50 and is one of the main causes of vision loss in the United States.
Potential cause of AMD identified
age-related macular degeneration

Potential cause of AMD identified

Researchers discovered a rare genetic variant that generates malformed proteins that change the stability of the membrane attack complex (MAC). 
How the eye gives us a glimpse into human aging
age related macular degeneration

How the eye gives us a glimpse into human aging

The eye has been said to be the window to the soul and it may also offer us a glimpse into human aging.

USA Only, Spend $50, get free shipping

Free shipping is currently available for orders within the United States only.